Speaker
Marco Capogni
(ENEA)
Summary
Bremsstrahlung imaging (BSI) is increasingly becoming more relevant thanks to the use of β⁻-emitter in radiometabolic therapies, offering the potential for patient-specific quantification of radiopharmaceutical biodistribution. However, its clinical implementation is challenged by the continuous photon energy spectrum and low bremsstrahlung yield. In this work, we extend our previous investigation on nearly pure ⁹⁰Y to explore critical aspects of BSI for the hybrid β⁻ emitter ¹⁶⁶Ho, aiming to improve quantitative imaging in therapeutic applications.
| Are you interested/eligible for the Young Session? | Yes, I am eligible and interested in participating |
|---|
Authors
Dr
Evaristo Cisbani
(ROMA1)
Marco Capogni
(ENEA)
S. Murri
(Azienda USL Toscana sud est, UOSD Fisica Sanitaria, Arezzo, Italy)
Valerio Cosmi
Co-authors
A. Capotosti
(Policlinico Universitario Fondazione Agostino Gemelli, Largo A. Gemelli, Roma, Italy)
A. Spurio
(Istituto Superiore di Sanità, Rome, Italy)
F. Giuliani
(Istituto Superiore di Sanità, Rome, Italy)
F. Santavenere
(Istituto Superiore di Sanità, Rome, Italy)
M. Pilade
(Sapienza University of Rome, Rome, Italy)
Maurizio Lucentini
(ROMA1)
Paolo Musico
(Istituto Nazionale di Fisica Nucleare)
